The PI3K pathway acting on alternative HIV-1 pre-mRNA splicing

References

1. Blaustein M., Pelisch F., Coso O. A., Bissell M. J., Kornblihtt A. R., Srebrow A. 2004; Mammary epithelial-mesenchymal interaction regulates fibronectin alternative splicing via phosphatidylinositol 3-kinase. J Biol Chem 279:21029–21037 [View Article][PubMed]
   [Google Scholar]
2. Blaustein M., Pelisch F., Tanos T., Muñoz M. J., Wengier D., Quadrana L., Sanford J. R., Muschietti J. P., Kornblihtt A. R.other authors 2005; Concerted regulation of nuclear and cytoplasmic activities of SR proteins by AKT. Nat Struct Mol Biol 12:1037–1044 [View Article][PubMed]
   [Google Scholar]
3. Borgatti P., Zauli G., Colamussi M. L., Gibellini D., Previati M., Cantley L. L., Capitani S. 1997; Extracellular HIV-1 Tat protein activates phosphatidylinositol 3- and Akt/PKB kinases in CD4+ T lymphoblastoid Jurkat cells. Eur J Immunol 27:2805–2811 [View Article][PubMed]
   [Google Scholar]
4. Briand G., Barbeau B., Tremblay M. 1997; Binding of HIV-1 to its receptor induces tyrosine phosphorylation of several CD4-associated proteins, including the phosphatidylinositol 3-kinase. Virology 228:171–179 [View Article][PubMed]
   [Google Scholar]
5. Chomczynski P., Sacchi N. 1987; Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159 [View Article][PubMed]
   [Google Scholar]
6. Chugh P., Bradel-Tretheway B., Monteiro-Filho C. M., Planelles V., Maggirwar S. B., Dewhurst S., Kim B. 2008; Akt inhibitors as an HIV-1 infected macrophage-specific anti-viral therapy. Retrovirology 5:11 [View Article][PubMed]
   [Google Scholar]
7. Diehl N., Schaal H. 2013; Make yourself at home: viral hijacking of the PI3K/Akt signaling pathway. Viruses 5:3192–3212 [View Article][PubMed]
   [Google Scholar]
8. Dowling D., Nasr-Esfahani S., Tan C. H., O’Brien K., Howard J. L., Jans D. A., Purcell D. F., Stoltzfus C. M., Sonza S. 2008; HIV-1 infection induces changes in expression of cellular splicing factors that regulate alternative viral splicing and virus production in macrophages. Retrovirology 5:18 [View Article][PubMed]
   [Google Scholar]
9. Dunn E. F., Connor J. H. 2012; HijAkt: The PI3K/Akt pathway in virus replication and pathogenesis. Prog Mol Biol Transl Sci 106:223–250 [View Article][PubMed]
   [Google Scholar]
10. Engelman J. A., Luo J., Cantley L. C. 2006; The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 7:606–619 [View Article][PubMed]
    [Google Scholar]
11. Erkelenz S., Mueller W. F., Evans M. S., Busch A., Schöneweis K., Hertel K. J., Schaal H. 2013a; Position-dependent splicing activation and repression by SR and hnRNP proteins rely on common mechanisms. RNA 19:96–102 [View Article][PubMed]
    [Google Scholar]
12. Erkelenz S., Poschmann G., Theiss S., Stefanski A., Hillebrand F., Otte M., Stühler K., Schaal H. 2013b; Tra2-mediated recognition of HIV-1 5′ splice site D3 as a key factor in the processing of vpr-mRNA. J Virol 87:2721–2734 [View Article][PubMed]
    [Google Scholar]
13. Exline C. M., Feng Z., Stoltzfus C. M. 2008; Negative and positive mRNA splicing elements act competitively to regulate human immunodeficiency virus type 1 vif gene expression. J Virol 82:3921–3931 [View Article][PubMed]
    [Google Scholar]
14. François F., Klotman M. E. 2003; Phosphatidylinositol 3-kinase regulates human immunodeficiency virus type 1 replication following viral entry in primary CD4+ T lymphocytes and macrophages. J Virol 77:2539–2549 [View Article][PubMed]
    [Google Scholar]
15. Huang J., Manning B. D. 2009; A complex interplay between Akt, TSC2 and the two mTOR complexes. Biochem Soc Trans 37:217–222 [View Article][PubMed]
    [Google Scholar]
16. Jäger S., Cimermancic P., Gulbahce N., Johnson J. R., McGovern K. E., Clarke S. C., Shales M., Mercenne G., Pache L.other authors 2012; Global landscape of HIV-human protein complexes. Nature 481:365–370[PubMed]
    [Google Scholar]
17. Jang S. W., Liu X., Fu H., Rees H., Yepes M., Levey A., Ye K. 2009; Interaction of Akt-phosphorylated SRPK2 with 14-3-3 mediates cell cycle and cell death in neurons. J Biol Chem 284:24512–24525 [View Article][PubMed]
    [Google Scholar]
18. Kammler S., Otte M., Hauber I., Kjems J., Hauber J., Schaal H. 2006; The strength of the HIV-1 3′ splice sites affects Rev function. Retrovirology 3:89 [View Article][PubMed]
    [Google Scholar]
19. Kim Y. K., Mbonye U., Hokello J., Karn J. 2011; T-cell receptor signaling enhances transcriptional elongation from latent HIV proviruses by activating P-TEFb through an ERK-dependent pathway. J Mol Biol 410:896–916 [View Article][PubMed]
    [Google Scholar]
20. Linnemann T., Zheng Y.-H., Mandic R., Peterlin B. M. 2002; Interaction between Nef and phosphatidylinositol-3-kinase leads to activation of p21-activated kinase and increased production of HIV. Virology 294:246–255 [View Article][PubMed]
    [Google Scholar]
21. Madsen J. M., Stoltzfus C. M. 2005; An exonic splicing silencer downstream of the 3′ splice site A2 is required for efficient human immunodeficiency virus type 1 replication. J Virol 79:10478–10486 [View Article][PubMed]
    [Google Scholar]
22. Mandal D., Feng Z., Stoltzfus C. M. 2010; Excessive RNA splicing and inhibition of HIV-1 replication induced by modified U1 small nuclear RNAs. J Virol 84:12790–12800 [View Article][PubMed]
    [Google Scholar]
23. Patel N. A., Chalfant C. E., Watson J. E., Wyatt J. R., Dean N. M., Eichler D. C., Cooper D. R. 2001; Insulin regulates alternative splicing of protein kinase C beta II through a phosphatidylinositol 3-kinase-dependent pathway involving the nuclear serine/arginine-rich splicing factor, SRp40, in skeletal muscle cells. J Biol Chem 276:22648–22654 [View Article][PubMed]
    [Google Scholar]
24. Patel N. A., Kaneko S., Apostolatos H. S., Bae S. S., Watson J. E., Davidowitz K., Chappell D. S., Birnbaum M. J., Cheng J. Q., Cooper D. R. 2005; Molecular and genetic studies imply Akt-mediated signaling promotes protein kinase CbetaII alternative splicing via phosphorylation of serine/arginine-rich splicing factor SRp40. J Biol Chem 280:14302–14309 [View Article][PubMed]
    [Google Scholar]
25. Purcell D. F., Martin M. A. 1993; Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity. J Virol 67:6365–6378[PubMed]
    [Google Scholar]
26. Schibeci S. D., Clegg A. O., Biti R. A., Sagawa K., Stewart G. J., Williamson P. 2000; HIV-Nef enhances interleukin-2 production and phosphatidylinositol 3-kinase activity in a human T cell line. AIDS 14:1701–1707 [View Article][PubMed]
    [Google Scholar]
27. Schrager J. A., Der Minassian V., Marsh J. W. 2002; HIV Nef increases T cell ERK MAP kinase activity. J Biol Chem 277:6137–6142 [View Article][PubMed]
    [Google Scholar]
28. Stoltzfus C. M. 2009; Chapter 1. Regulation of HIV-1 alternative RNA splicing and its role in virus replication. Adv Virus Res 74:1–40 [View Article][PubMed]
    [Google Scholar]
29. Widera M., Erkelenz S., Hillebrand F., Krikoni A., Widera D., Kaisers W., Deenen R., Gombert M., Dellen R.other authors 2013; An intronic G run within HIV-1 intron 2 is critical for splicing regulation of vif mRNA. J Virol 87:2707–2720 [View Article][PubMed]
    [Google Scholar]
30. Witte V., Laffert B., Gintschel P., Krautkrämer E., Blume K., Fackler O. T., Baur A. S. 2008; Induction of HIV transcription by Nef involves Lck activation and protein kinase C theta raft recruitment leading to activation of ERK1/2 but not NF kappa B. J Immunol 181:8425–8432 [View Article][PubMed]
    [Google Scholar]
31. Wolf D., Witte V., Laffert B., Blume K., Stromer E., Trapp S., d’Aloja P., Schürmann A., Baur A. S. 2001; HIV-1 Nef associated PAK and PI3-kinases stimulate Akt-independent Bad-phosphorylation to induce anti-apoptotic signals. Nat Med 7:1217–1224 [View Article][PubMed]
    [Google Scholar]
32. Zahler A. M., Damgaard C. K., Kjems J., Caputi M. 2004; SC35 and heterogeneous nuclear ribonucleoprotein A/B proteins bind to a juxtaposed exonic splicing enhancer/exonic splicing silencer element to regulate HIV-1 tat exon 2 splicing. J Biol Chem 279:10077–10084 [View Article][PubMed]
    [Google Scholar]
33. Zhou Z., Qiu J., Liu W., Zhou Y., Plocinik R. M., Li H., Hu Q., Ghosh G., Adams J. A.other authors 2012; The Akt-SRPK-SR axis constitutes a major pathway in transducing EGF signaling to regulate alternative splicing in the nucleus. Mol Cell 47:422–433 [View Article][PubMed]
    [Google Scholar]